Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Summary
The bill amends ERISA so that any group health plan must provide cost‑sharing for oral anticancer medicines on terms no less favorable than for anticancer drugs administered by a health‑care provider. It applies to employees and their dependents who receive coverage through such plans. The goal is to prevent higher out‑of‑pocket costs for oral cancer pills compared with infused treatments.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Track this bill
Get real-time alerts when S 5004 changes status, plus AI-powered summaries and stage predictions.
Sign up free